Literature DB >> 22750132

Effective radiation dose in CT colonography: is there a downward trend?

Thierry N Boellaard1, Henk W Venema, Geert J Streekstra, Jaap Stoker.   

Abstract

RATIONALE AND
OBJECTIVES: Radiation dose is an important drawback of computed tomography (CT) colonography, especially for its use as a screening tool for colorectal cancer. It is therefore important to know the present radiation dose. Our objective is to assess the effective radiation doses used for CT colonography and its trend over time.
MATERIALS AND METHODS: Institutions performing CT colonography research were asked to provide their CT colonography protocols. Median effective doses were calculated and compared with a 2007 inventory. Separate analyses were performed for protocols using intravenous contrast medium and for academic versus nonacademic institutions. Differences in effective dose were tested for significance, using Wilcoxon rank-sum or Wilcoxon signed-rank test.
RESULTS: Sixty-two of 109 (57%) institutions responded, providing protocols for 58 institutions. Median effective dose for daily practice protocols was 7.6 mSv (4.3 mSv and 2.0 mSv for supine and prone, respectively) and for screening 4.4 mSv (2.6 mSv and 2.0 mSv, respectively; P = .01). For daily practice with and without contrast medium, the median effective doses were 10.5 mSv and 4.0 mSv (P < .001), respectively. Academic and nonacademic institutions used similar doses (all comparisons P > .05). For institutions also participating in the 2007 inventory, effective dose for both daily practice and screening protocols were similar (P > .05).
CONCLUSION: In 2011 the median effective radiation dose for daily practice protocols was 7.6 mSv and for screening 4.4 mSv. Median effective doses have not decreased as compared to 2007. Academic and nonacademic institutions use similar radiation dose.
Copyright © 2012 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750132     DOI: 10.1016/j.acra.2012.04.013

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

1.  Sub-milliSievert (sub-mSv) CT colonography: a prospective comparison of image quality and polyp conspicuity at reduced-dose versus standard-dose imaging.

Authors:  Meghan G Lubner; B Dustin Pooler; Douglas R Kitchin; Jie Tang; Ke Li; David H Kim; Alejandro Munoz del Rio; Guang-Hong Chen; Perry J Pickhardt
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

2.  Evaluation of dose reduction and image quality in CT colonography: comparison of low-dose CT with iterative reconstruction and routine-dose CT with filtered back projection.

Authors:  Koichi Nagata; Masanori Fujiwara; Hidenori Kanazawa; Tomohiro Mogi; Nao Iida; Toru Mitsushima; Alan T Lefor; Hideharu Sugimoto
Journal:  Eur Radiol       Date:  2014-08-06       Impact factor: 5.315

Review 3.  CT colonography for population screening of colorectal cancer: hints from European trials.

Authors:  Lapo Sali; Daniele Regge
Journal:  Br J Radiol       Date:  2016-09-14       Impact factor: 3.039

4.  [Colorectal cancer: role of imaging in screening].

Authors:  T Mang
Journal:  Radiologe       Date:  2019-01       Impact factor: 0.635

5.  British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines.

Authors:  Matthew D Rutter; James East; Colin J Rees; Neil Cripps; James Docherty; Sunil Dolwani; Philip V Kaye; Kevin J Monahan; Marco R Novelli; Andrew Plumb; Brian P Saunders; Siwan Thomas-Gibson; Damian J M Tolan; Sophie Whyte; Stewart Bonnington; Alison Scope; Ruth Wong; Barbara Hibbert; John Marsh; Billie Moores; Amanda Cross; Linda Sharp
Journal:  Gut       Date:  2019-11-27       Impact factor: 31.793

6.  Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline.

Authors:  Cristiano Spada; Jaap Stoker; Onofre Alarcon; Federico Barbaro; Davide Bellini; Michael Bretthauer; Margriet C De Haan; Jean-Marc Dumonceau; Monika Ferlitsch; Steve Halligan; Emma Helbren; Mikael Hellstrom; Ernst J Kuipers; Philippe Lefere; Thomas Mang; Emanuele Neri; Lucio Petruzziello; Andrew Plumb; Daniele Regge; Stuart A Taylor; Cesare Hassan; Andrea Laghi
Journal:  Eur Radiol       Date:  2015-02       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.